Methylene blue: a controversial diagnostic acid and medication?

M Bužga, E Machytka, E Dvořáčková… - Toxicology …, 2022 - academic.oup.com
A narrative review of the literature was conducted to determine if the administration of
methylene blue (MB) in humans has potential risks. Studies were identified from MEDLINE …

Methylene blue and serotonin toxicity: inhibition of monoamine oxidase A (MAO A) confirms a theoretical prediction

RR Ramsay, C Dunford… - British journal of …, 2007 - Wiley Online Library
Background and purpose: Monoamine oxidase inhibitors (MAOI) are known to cause
serotonin toxicity (ST) when administered with selective serotonin reuptake inhibitors (SSRI) …

Synthetic and natural monoamine oxidase inhibitors as potential lead compounds for effective therapeutics

A Pathak, AK Srivastava, PK Singour… - … System Agents in …, 2016 - ingentaconnect.com
Monoamine oxidases A and B (MAO-A and B) play a critical role in the metabolism of
intracellular neurotransmitters of the central nervous system. For decades, MAO inhibitors …

Management of severe arterial hypertension associated with serotonin syndrome: a case report analysis based on systematic review techniques

M Ott, JK Mannchen, F Jamshidi… - Therapeutic advances …, 2019 - journals.sagepub.com
Serotonin syndrome is thought to arise from serotonin excess. In many cases, symptoms are
mild and self-limiting. But serotonin syndrome can become life threatening, when …

The blue coma: the role of methylene blue in unexplained coma after cardiac surgery

EA Martino, D Winterton, P Nardelli, L Pasin… - … of Cardiothoracic and …, 2016 - Elsevier
Objectives Methylene blue commonly is used as a dye or an antidote, but also can be used
off label as a vasopressor. Serotonin toxicity is a potentially lethal and often misdiagnosed …

Clinical drug-drug interactions: focus on venlafaxine

P Magalhães, G Alves, A LLerena… - Drug metabolism and …, 2015 - degruyter.com
Venlafaxine (VEN) is an antidepressant agent widely used nowadays as an alternative to
selective serotonin reuptake inhibitors (SSRIs), particularly for the treatment of SSRI …

60 Years of combining tranylcypromine: A systematic review of available evidence

E Wagner, F Seemueller, A Hasan - Journal of Clinical …, 2022 - journals.lww.com
Background Tranylcypromine is the only irreversible monoamine oxidase inhibitor that is
approved in the United States and in Europe for the management of treatment-resistant …

[PDF][PDF] フルボキサミンとタンドスピロンによるセロトニン症候群により日本で初めて死亡した1 例

川野貴久, 小菅宇之, 高木俊介, 下山哲, 春成伸之… - jsct-web.umin.jp
Summary(Jpn J Clin Toxicol 2011; 24: 305-310) We experienced the first death case of the
serotonin syndrome in Japan caused by fluvoxamine and tandospirone. A 15-year-old man …

[引用][C] Venlafaxine–lithium toxicity: suitability for use in the elderly

DK Gillman - Journal of clinical pharmacy and therapeutics, 2007 - Wiley Online Library
To the Editor: Adan-Manes et al.(1) have described a useful and instructive case report and
analysis of venlafaxine induced serotonin toxicity (ST) with lithium. I suggest some points will …

[引用][C] The Blue Coma: the role of methylene blue in unexplained coma after cardiac surgery. A case series

EA Martino, D Winterton, P Nardelli, L Pasin… - J Cardiothorac Vasc Anesth, 2015